New patent for Novo Nordisk drug RYZODEG 70/30

Annual Drug Patent Expirations for RYZODEG+70%2F30 Ryzodeg 70/30 is a drug marketed by Novo Nordisk Inc and is included in one NDA. There are fifteen patents protecting this drug. Drug… The post New patent for Novo Nordisk drug RYZODEG 70/30 appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.

Do NOT follow this link or you will be banned from the site!